Blood Product Requirement in Childhood Acute Lymphoblastic Leukemia in Relation to Chemotherapy Regimens

Creative Commons License

Gudeloglu E., Albayrak D.

IRANIAN JOURNAL OF PEDIATRICS, cilt.30, sa.3, 2020 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5812/ijp.100823
  • Dergi Adı: IRANIAN JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, Veterinary Science Database
  • Anahtar Kelimeler: Acute Lymphoblastic Leukemia, Blood Transfusions, Chemotherapy, Child, CELL TRANSFUSION, CHILDREN, SURVIVAL
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Background: Along with lack of studies that systematically address the transfusion requirements and triggers in acute leukemia, no study to date has addressed the blood product use with respect to ongoing chemotherapy (CT) in pediatric acute lymphoblastic leukemia (ALL) patients.